Stock ILMN ILLUMINA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Illumina, Inc.

Equities

ILMN

US4523271090

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-01 pm EDT 		5-day change 1st Jan Change
124.7 USD +1.32% Intraday chart for Illumina, Inc. +1.47% -10.46%
Apr. 22 Bernstein Adjusts Price Target on Illumina to $129 From $150 MT
Apr. 22 Baird Adjusts Price Target on Illumina to $125 From $146, Neutral Rating Kept MT

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Illumina Secures European Commission's Approval for Grail Divestment
MT
European Commission Clears Illumina's Proposed Sale of Cancer Test Maker Grail
MT
US Equity Markets Close Higher Thursday, Extending Gains From Wednesday
MT
Illumina Shares Up After EU Court Adviser Says Antitrust Regulators Overstepped in Halting Grail Merger
MT
Boost for Illumina as court adviser rejects EU merger powers
RE
EU court should back Illumina's appeal against EU review of Grail deal, court adviser says
RE
Exclusive-Icahn drops Illumina board challenge threat, sources say
RE
Tranche Update on Illumina, Inc.'s Equity Buyback Plan announced on February 11, 2020.
CI
Illumina, already facing pressure from Icahn, saw other activists at year end
RE
Illumina forecasts flat 2024 sales as sluggish demand drags on
RE
Illumina's Q4 Non-GAAP Earnings Unchanged, Revenue Rises
MT
Illumina, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
CI
Earnings Flash (ILMN) ILLUMINA Posts Q4 EPS $0.14 vs. Street Est of $0.01
MT
Earnings Flash (ILMN) ILLUMINA Reports Q4 Revenue $1.12B vs. Street Est of $1.11B
MT
Illumina, Inc. Provides Earnings Guidance for the Fiscal Year 2024
CI
Walt Disney Nominates 12 to Board of Directors, Says CEO Iger's Compensation Doubled in 2023
DJ
Concentric by Ginkgo and Illumina Collaborate to Deploy Biosurveillance Technologies Around the World
CI
Illumina Reports Higher Q4 Preliminary Unaudited Revenue, Lower Preliminary Unaudited 2023 Revenue
MT
Devyser Diagnostics Teams Up with Illumina to Offer IVD Tests in Europe, US
MT
Devyser Diagnostics AB Signs in Vitro Diagnostic Agreement with Illumina to Broaden Access to Its Tests
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ILMN Stock
  4. News Illumina, Inc.
  5. Highlights